Related Experiment Video
Updated: Sep 11, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Targeting the CAPON-NOS Axis: A Computational Strategy for Small Molecule Modulator Discovery
Researchers identified two compounds to disrupt the neuronal nitric oxide synthase (nNOS)/CAPON protein interaction, a key target for neurological and cardiac disorders. Novel computational tools were also developed to accelerate drug discovery.
Area of Science:
- Biochemistry and Molecular Biology
- Pharmacology and Drug Discovery
- Computational Chemistry
Background:
- Neuronal nitric oxide synthase (nNOS) interacts with the carboxy-terminal PDZ ligand of nNOS (CAPON) protein.
- This nNOS/CAPON interaction regulates nitric oxide (NO) signaling in neurological, cardiac, and metabolic functions.
- Dysregulation of nNOS/CAPON is implicated in various pathological conditions, presenting a therapeutic target.
Purpose of the Study:
- To develop the first strategy targeting the disruption of the nNOS/CAPON protein-protein interface.
- To identify small molecule modulators of the nNOS/CAPON interaction for potential therapeutic applications.
- To introduce novel computational tools to enhance structure-based drug discovery.
Main Methods:
- High-throughput virtual screening of 4.6 million compounds.
- Eight molecular dynamics simulations to analyze protein-protein interactions.
- Development of Python-based toolkits for NMR structural analysis and ligand preparation.
Main Results:
- Identification of two potential hit compounds capable of disrupting the nNOS/CAPON interface.
- Development of freely available computational tools that accelerate data preparation and reduce costs.
- Demonstration of a scalable computational framework for protein-protein interaction drug discovery.
Conclusions:
- This study presents a foundational strategy for developing targeted therapies for CAPON-mediated disorders.
- The identified compounds and novel computational tools represent significant advancements in drug discovery for nNOS/CAPON related conditions.
- The developed tools offer accessible resources for the research community to conduct efficient and reproducible virtual screening campaigns.
More Related Videos
10:20Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
Drug Discovery: Overview
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...